Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veldona for Relapse Prevention in Hepatitis C
NCT00695019Phase 2Completed
- Sponsor
- Ainos, Inc.
- Start
- Jun 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veldona in hepatitis C (HCV), sponsored by Ainos, Inc.. Started Jun 2009; status: completed.
02
Drugs
veldona
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00695019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00695019.